High Pasta vs. Low Pasta Diet in the Treatment of Obesity

May 3, 2018 updated by: Francesca Scazzina Ph.D., University of Parma

The Effect of High Pasta vs. Low Pasta Mediterranean Diet on Weight Loss in the Treatment of Obese Patients

To the best of our knowledge, the effect of pasta consumption within a hypocaloric Mediterranean diet has only been scarcely explored yet. Therefore, a two-parallel group dietary intervention was carried out to investigate if pasta consumption could affect the BMI change in obese patients. The primary outcome was the loss of at leat 8% of the initial body weight in the first 6 months. Anthropometric and body composition (from bioelectrical impedance analysis - BIA-) measures were collected every month for the first 6 months and after 1 year. In addition, dietary information was collected at baseline and after 3, 6 and 12 months through a 7-day carbohydrate food record and a 24-h food recall. Blood samples were collected at baseline and at 6 and 12 months to assess: glucose, insulin, Homeostatic model assessment for insulin resistant (HOMA-IR) index, total cholesterol, low-density lipoprotein, high-density lipoprotein, and uric acid. Furthermore, the perceived quality of life was investigated through the 36-items short form health survey (SF36) questionnaire.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Anticipated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Parma, Italy, 43125
        • Department of Food and Drug, University of Parma

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 30-45 kg/m2
  • healthy subjects
  • regular meal consumption
  • no celiac disease
  • no menopause woman

Exclusion Criteria:

  • with a BMI <30 or >45 kg/m2
  • having diabetes, hepatic or kidney diseases
  • having an eating disorder
  • having celiac disease
  • menopause woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Pasta
Habitual pasta consumption equal or higher than 5 times/week.
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (at least 5 times/week). To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.
Experimental: Low Pasta
Habitual pasta consumption equal or lower than 3 times/week.
Participants received a personalised diet program considering their food preferences and eating behaviour, based on the Italian guidelines for a healthy and Mediterranean diet and were encouraged to maintain their habitual consumption of pasta (no more than 3 times/week). To encourage participants to prepare healthy meals by using high-quality ingredients, participants were provided with a recipe book and dietary guidelines and recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Body weight at 6 months
Time Frame: baseline, 6 months
Measured in kg according to the standard procedure
baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline Body weight at 3 months
Time Frame: baseline, 3 months
Measured in kg according to the standard procedure
baseline, 3 months
Change from baseline Body weight at 12 months
Time Frame: baseline, 12 months
Measured in kg according to the standard procedure
baseline, 12 months
BMI
Time Frame: baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
Calculated as body weight in kilograms divided by the square of the height in meters
baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
Waist circumference
Time Frame: baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
Measured in cm according to the standard procedure
baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 12 months
Free Fat Mass
Time Frame: baseline, 3 months, 6 months, 12 months
Estimated by bioelectrical impedance analysis in kg and in %
baseline, 3 months, 6 months, 12 months
Fat Mass
Time Frame: baseline, 3 months, 6 months, 12 months
Estimated by bioelectrical impedance analysis in kg and in %
baseline, 3 months, 6 months, 12 months
Basal Metabolic Rate
Time Frame: baseline, 3 months, 6 months, 12 months
Estimated by bioelectrical impedance analysis in kcal/day
baseline, 3 months, 6 months, 12 months
Glucose
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
Insulin
Time Frame: baseline, 6 months, 12 months
microU/mL in fasting condition
baseline, 6 months, 12 months
HOMA-IR index
Time Frame: baseline, 6 months, 12 months
calculated from glucose and insulin in fasting condition
baseline, 6 months, 12 months
Total cholesterol
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
HDL cholesterol
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
LDL cholesterol
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
Triglycerides
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
Uric Acid
Time Frame: baseline, 6 months, 12 months
mg/dL in fasting condition
baseline, 6 months, 12 months
Energy intake
Time Frame: baseline, 3 months, 6 months, 12 months
assessed by a 24-h dietary recall as kcal/day
baseline, 3 months, 6 months, 12 months
Nutrient intakes
Time Frame: baseline, 3 months, 6 months, 12 months
assessed by a 24-h dietary recall as g/day
baseline, 3 months, 6 months, 12 months
Carbohydrate-based food intakes
Time Frame: baseline, 3 months, 6 months, 12 months
assessed by a 7-day food diary as times/week
baseline, 3 months, 6 months, 12 months
Perceived Quality of Life
Time Frame: baseline, 3 months, 6 months, 12 months
assessed by the SF36 questionnaire
baseline, 3 months, 6 months, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Elisabetta Dall'Aglio, MD, University of Parma

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 2, 2015

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

November 7, 2017

First Submitted That Met QC Criteria

November 13, 2017

First Posted (Actual)

November 14, 2017

Study Record Updates

Last Update Posted (Actual)

May 4, 2018

Last Update Submitted That Met QC Criteria

May 3, 2018

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • SP2

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diet Therapy

Clinical Trials on High Pasta

Subscribe